FTC pauses lawsuit against PBMs over insulin pricing

The Federal Trade Commission is pressing pause on its legal fight with major pharmacy benefit managers (PBMs).

Previous
Previous

“Slow Pay, Low Pay or No Pay”

Next
Next

Proposed Legislation Could Address Pharmacy Closures, Save Medicaid $2 Billion Over 10 Years